Girolamo Todd C 4
4 · PROKIDNEY CORP. · Filed Mar 3, 2026
Research Summary
AI-generated summary of this filing
ProKidney (PROK) Chief Legal Officer Todd Girolamo Receives Award
What Happened Todd C. Girolamo, Chief Legal Officer of ProKidney Corp. (PROK), received a grant of derivative securities on March 1, 2026 covering 600,000 shares. The Form 4 reports an acquisition-type transaction (A) at a reported price of $0.00; the award is a stock option (derivative) rather than an open-market purchase or sale.
Key Details
- Transaction date: 2026-03-01; Filing date: 2026-03-03.
- Instrument: Award/grant of derivative securities (reported as options) for 600,000 shares at $0.00.
- Vesting: Per footnote, the option vests in substantially equal monthly installments over four years beginning March 1, 2026.
- Shares owned after transaction: Not specified in the information provided in this summary.
- Filing timeliness: Filing date is Mar 3 for a Mar 1 transaction; the Form 4 does not indicate a late filing flag in the supplied excerpt.
Context This transaction is a compensation-related option grant, not a purchase (bullish signal) or sale. Such awards are common for executive compensation and vest over time, which means any economic benefit depends on future vesting and the company’s stock performance. The footnote clarifies the vesting schedule; there is no indication these shares were immediately sold or transferred.
Insider Transaction Report
- Award
Employee stock option (right to buy)
[F1]2026-03-01+600,000→ 600,000 totalExercise: $2.24Exp: 2036-03-01→ Class A Common Stock (600,000 underlying)
Footnotes (1)
- [F1]The option vests in substantially equal monthly installments over the four year period beginning on March 1, 2026.